08:48 AM EST, 11/05/2025 (MT Newswires) -- Crescita Therapeutics ( CRRTF ) (CTX .TO) on Wednesday reported a third-quarter profit as revenue rose.

The skincare company reported net income of $753,000 or $0.04 per share, compared with a loss of $1 million, or $0.05 per share, in the prior year period.

Revenue rose to $5.4 million, from $3.6 million over the same period. Crescita attributed the increase to the fulfillment of large orders in its manufacturing segment, including the ramp-up in production volumes for a new customer.